BLAZER PRIME XP TEMPERATURE ABLATION CATHETER
FDA premarket approval P020025/S035 · decided 2012-09-21
Approval details
- PMA number
- P020025
- Supplement
- S035
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- BLAZER PRIME XP TEMPERATURE ABLATION CATHETER
- Generic name
- catheter, percutaneous, cardiac ablation, for treatment of atrial flutter
- Applicant
- Boston Scientific
- Date received
- 2012-09-05
- Decision date
- 2012-09-21
- Days to decision
- 16 days
- Decision code
- OK30
- Product code
- OAD
- Advisory committee
- Cardiovascular
- Expedited review
- No
- Location
- St Paul, MN
- Statement
- USE OF NEW STATISTICAL PROCESS CONTROL SOFTWARE.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.